Allt inom mfn-ext-nq-company-announcement

Nanexa, is pleased to announce that the company has been selected as a finalist in the Drug Delivery Technology category by the renowned industry publication Fierce Life Sciences. The annual Fierce Life Sciences Innovation Awards identify and showcase outstanding innovation that is driving improvements in life science technologies. Their panel of expert judges has identified Nanexa as a company whose pioneering solutions have the potential to create efficiencies, engage patients, or revolutionize the pharmaceutical industry.

The approval strengthens Nanexa’s patent portfolio, with additional patent applications filed in other strategically important countries